Effect of evobrutinib, a Bruton's tyrosine kinase inhibitor, on patient-reported vitality and mental health in patients with relapsing multiple sclerosis in a Phase 2 trial

Multiple Sclerosis and Related Disorders(2023)

引用 0|浏览3
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要